Clinical trial
Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection
NCT01162265 is registered in ClinicalTrials.gov with Public Health England as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection
- Lead sponsor
- Public Health England
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- June 30, 2016
- Enrollment
- 10,000 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.